Stay updated on Nivolumab for Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Prostate Cancer Clinical Trial page.

Latest updates to the Nivolumab for Prostate Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added, and the funding-lapse notice along with the prior Revision: v3.4.1 entry were removed.SummaryDifference0.4%

- Check20 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the page revision from v3.4.0 to v3.4.1; there are no changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedThe changes are minor UI and metadata updates (Show glossary option; the label 'Last Update Submitted that Met QC Criteria'; capitalization adjustments; and a new revision version to v3.4.0) that do not alter core study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 in the page footer, with no changes to study details or core content; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedRemoved the 'Prostate cancer' topic and the related topic 'MedlinePlus Genetics' from the page.SummaryDifference0.2%

- Check56 days agoChange DetectedAdded related topics: Prostate cancer and MedlinePlus Genetics to the page. These additions provide navigation context without altering the trial details.SummaryDifference0.2%

Stay in the know with updates to Nivolumab for Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Prostate Cancer Clinical Trial page.